Freek W A Verheugt, Keith A A Fox, Saverio Virdone, Giuseppe Ambrosio, Bernard J Gersh, Sylvia Haas, Karen S Pieper, Gloria Kayani, A John Camm, Alexandr Parkhomenko, Frank Misselwitz, APHany Ragy, Hugo Ten Cate, Matyas Keltai, Ajay K Kakkar
BACKGROUND: Many patients with atrial fibrillation suffer from comorbid vascular disease. The comparative efficacy and safety of different types of oral anticoagulation (OAC) in this patient group have not been widely studied. METHODS: Adults with newly-diagnosed atrial fibrillation were recruited into the prospective observational registry, GARFIELD-AF, and followed for 24 months. Associations of vascular disease with clinical outcomes were analysed using adjusted hazard ratios (HR), obtained via Cox proportional-hazard modelling...
September 11, 2023: American Journal of Medicine